No. of Pages: 134 | Report Code: BMIRE00026306 | Category: Life Sciences
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Human Papillomavirus (HPV) Vaccines Market – By Type
1.3.2 SAM Human Papillomavirus (HPV) Vaccines Market – By Dosage
1.3.3 SAM Human Papillomavirus (HPV) Vaccines Market – By Age
1.3.4 SAM Human Papillomavirus (HPV) Vaccines Market – By Application
1.3.5 SAM Human Papillomavirus (HPV) Vaccines Market – By Distribution Channel
1.3.6 SAM Human Papillomavirus (HPV) Vaccines Market – By Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5.1 Market Drivers
5.1.1 Increase in Prevalence of HPV Associated Diseases
5.1.2 Initiatives Taken by Health Organizations
5.2 Market Restraints
5.2.1 High Cost of HPV Vaccines
5.3 Future Trends
5.3.1 Advancements in HPV Diagnostics Tests
5.4 Impact Analysis
6.1 SAM Human Papillomavirus (HPV) Vaccine Market Revenue Forecast and Analysis
7.1 Overview
7.2 By Type: Market Revenue and Forecast Analysis (US$ Million)
7.3 9-valent HPV vaccine
7.3.1 Overview
7.3.2 9-valent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
7.4 Quadrivalent HPV vaccine
7.4.1 Overview
7.4.2 Quadrivalent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
7.5 Bivalent HPV Vaccine
7.5.1 Overview
7.5.2 Bivalent HPV Vaccine Market Revenue and Forecast to 2028 (US$ Million)
8.1 SAM Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Dosage (2022 and 2028)
8.2 2 Dose
8.2.1 Overview
8.2.2 2 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
8.3 3 Dose
8.3.1 Overview
8.3.2 3 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
9.1 SAM Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Age (2022 and 2028)
9.2 9 to 14 Years
9.2.1 Overview
9.2.2 9 to 14 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
9.3 to 45 Years
9.3.1 Overview
9.3.2 to 45 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
10.1 SAM Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Application (2022 and 2028)
10.2 HPV-attributable Cancer
10.2.1 Overview
10.2.2 HPV-attributable Cancer: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
10.3 Genital Warts
10.3.1 Overview
10.3.2 Genital Warts: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
11.1 Overview
11.2 SAM Human Papillomavirus (HPV) Vaccine Market Revenue Share, by End User (2022 and 2028)
11.3 Doctor Office
11.3.1 Overview
11.3.2 Doctor Office Market Revenue and Forecast to 2028 (US$ Million)
11.4 Community Health Clinics
11.4.1 Overview
11.4.2 Community Health Clinics Market Revenue and Forecast to 2028 (US$ Million)
11.5 School-based Health Centers
11.5.1 Overview
11.5.2 School-based Health Centers Market Revenue and Forecast to 2028 (US$ Million)
11.6 Health Departments
11.6.1 Overview
11.6.2 Health Departments Market Revenue and Forecast to 2028 (US$ Million)
11.7 Hospitals
11.7.1 Overview
11.7.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)
11.8 Others
11.8.1 Overview
11.8.2 Others Market Revenue and Forecast to 2028 (US$ Million)
12.1 Overview
12.1.1 SAM: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Country (%)
12.1.1.1 Argentina Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.1 Overview
12.1.1.1.2 Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
12.1.1.1.3 Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
12.1.1.1.4 Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
12.1.1.1.5 Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
12.1.1.1.6 Argentina: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.7 Argentina: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
12.1.1.2 Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.1 Overview
12.1.1.2.2 Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
12.1.1.2.3 Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
12.1.1.2.4 Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
12.1.1.2.5 Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
12.1.1.2.6 Brazil: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.7 Brazil: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
12.1.1.3 Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.1 Overview
12.1.1.3.2 Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
12.1.1.3.3 Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
12.1.1.3.4 Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
12.1.1.3.5 Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
12.1.1.3.6 Chile: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.7 Chile: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
12.1.1.4 Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.4.1 Overview
12.1.1.4.2 Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
12.1.1.4.3 Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
12.1.1.4.4 Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
12.1.1.4.5 Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
12.1.1.4.6 Guatemala: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.1.4.7 Guatemala: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
12.1.1.5 Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.5.1 Overview
12.1.1.5.2 Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
12.1.1.5.3 Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
12.1.1.5.4 Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
12.1.1.5.5 Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
12.1.1.5.6 Peru: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.1.5.7 Peru: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
12.1.1.6 Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.6.1 Overview
12.1.1.6.2 Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
12.1.1.6.3 Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
12.1.1.6.4 Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
12.1.1.6.5 Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
12.1.1.6.6 Colombia: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.1.6.7 Colombia: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
12.1.1.7 Rest of South and Central America: Human Papillomavirus (HPV) Vaccine Market– Revenue and Forecast to 2028 (USD Million)
12.1.1.7.1 Overview
12.1.1.7.2 Rest of SAM: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
12.1.1.7.3 Rest of SAM: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
12.1.1.7.4 Rest of SAM: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
12.1.1.7.5 Rest of SAM: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
12.1.1.7.6 Rest of SAM: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.1.7.7 Rest of SAM: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
13.1 Overview
13.2 Inorganic Growth Strategies
13.2.1 Overview
13.3 Organic Growth Strategies
13.3.1 Overview
14.1 Merck & Co., Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 GlaxoSmithKline plc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Serum Institute of India Pvt. Ltd
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Inovio Pharmaceuticals
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Sanofi
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 R-Pharm
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
15.1 About The Insight Partners
15.2 Glossary of Terms
Table 1. SAM Human Papillomavirus (HPV) Vaccine Market, Revenue and Forecast, 2019–2028 (US$ Mn)
Table 2. Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 3. Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 4. Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 5. Argentina: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 8. Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 9. Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 10. Brazil: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 11. Brazil: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 12. Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 13. Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 14. Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 15. Chile: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Chile: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 17. Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 18. Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 19. Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 20. Guatemala: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 21. Guatemala: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 22. Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 23. Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 24. Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 25. Peru: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 26. Peru: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 27. Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 28. Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 29. Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 30. Colombia: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 31. Colombia: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of SAM: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 33. Rest of SAM: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 34. Rest of SAM: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 35. Rest of SAM: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of SAM: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 37. Recent Inorganic Growth Strategies
Table 38. Recent Organic Growth Strategies
Table 39. Glossary of Terms
Figure 1. SAM Human Papillomavirus (HPV) Vaccines Market Segmentation
Figure 2. SAM Human Papillomavirus (HPV) Vaccines Market, By Country
Figure 3. SAM Human Papillomavirus (HPV) Vaccine Market Overview
Figure 4. SAM Human Papillomavirus (HPV) Vaccines Market, By Type
Figure 5. SAM Human Papillomavirus (HPV) Vaccines Market, By Country
Figure 6. SAM: PEST Analysis
Figure 7. Experts Opinion
Figure 8. SAM Human Papillomavirus (HPV) Vaccines Market Impact Analysis of Driver and Restraints
Figure 9. SAM Human Papillomavirus (HPV) Vaccine Market– Revenue Forecast and Analysis
Figure 10. By Type: Market Analysis and Forecast 2022 and 2028 (%)
Figure 11. SAM 9-valent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. SAM Quadrivalent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. SAM Bivalent HPV Vaccine Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. SAM Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Dosage (2022 and 2028)
Figure 15. SAM 2 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. SAM 3 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. SAM Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Age (2022 and 2028)
Figure 18. SAM 9 to 14 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. SAM 15 to 45 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. SAM Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Application (2022 and 2028)
Figure 21. SAM HPV-attributable Cancer: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. SAM Genital Warts: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. SAM Human Papillomavirus (HPV) Vaccine Market Revenue Share, by End User (2022 and 2028)
Figure 24. SAM Doctor Office Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. SAM Community Health Clinics Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. SAM School-based Health Centers Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. SAM Health Departments Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. SAM Hospitals Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. SAM Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. SAM Human Papillomavirus (HPV) Vaccine Market Overview, by Country (2022)
Figure 31. SAM: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Country (%)
Figure 32. Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. Rest of SAM: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South America Human Papillomavirus (HPV) Vaccine Market
